image
Vertex Pharmaceuticals Incorporated VRTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 490.47
-2.37 %
$ 126 B
Market Cap
-227.39
P/E
Price Target Average
2.25%
Revenue Forecast Estimate
11.78%
EBIT Estimate
132.25%
Net Income Estimate
98.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Vertex Pharmaceuticals Incorporated
image
Wall Street analysts predict an average 1-year price target for VRTX of $502 , with forecasts ranging from a low of $361 to a high of $600 .
VRTX Lowest Price Target Wall Street Target
361 USD -26.40%
VRTX Average Price Target Wall Street Target
502 USD 2.25%
VRTX Highest Price Target Wall Street Target
600 USD 22.33%
Price
Max Price Target
Min Price Target
Average Price Target
600600550550500500450450400400350350Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart VRTX

image
$18.0b$18.0b$16.0b$16.0b$14.0b$14.0b$12.0b$12.0b$10.0b$10.0b$8.0b$8.0b$6.0b$6.0b$4.0b$4.0b$2.0b$2.0b$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart VRTX

image
$7.0b$7.0b$6.0b$6.0b$5.0b$5.0b$4.0b$4.0b$3.0b$3.0b$2.0b$2.0b$1.0b$1.0b$0.0$0.0($1.0b)($1.0b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart VRTX

image
$8.0b$8.0b$7.0b$7.0b$6.0b$6.0b$5.0b$5.0b$4.0b$4.0b$3.0b$3.0b$2.0b$2.0b$1.0b$1.0b$0.0$0.0($1.0b)($1.0b)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029